Inventor · disambiguated record
Braydon Charles Guild
Also filed as: GUILD BRAYDON C · GUILD BRAYDON CHARLES
58 granted patents·32 pending applications·1,784 citations·filing 1992–2025
99Inventor score
Files withTRANSLATE BIO INC60SHIRE HUMAN GENETIC THERAPIES10NOVARTIS AG5GUILD BRAYDON CHARLES4APOPTOSIS TECHNOLOGY INC3
Top patents by PatentIndex Score
90 records- 0199US11291734B2Lipid nanoparticle compositions and methods for mRNA deliveryTRANSLATE BIO INC·Filed 2021·Granted Apr 5, 2022·10 cites·24 claims
- 0299US11185595B2Lipid nanoparticle compositions and methods for mRNA deliveryTRANSLATE BIO INC·Filed 2021·Granted Nov 30, 2021·7 cites·18 claims
- 0399US11052159B2Lipid nanoparticle compositions and methods for mRNA deliveryTRANSLATE BIO INC·Filed 2020·Granted Jul 6, 2021·10 cites·19 claims
- 0499US10888626B2Lipid nanoparticle compositions and methods for mRNA deliveryTRANSLATE BIO INC·Filed 2020·Granted Jan 12, 2021·13 cites·22 claims
- 0599US10238754B2Lipid nanoparticle compositions and methods for MRNA deliveryTRANSLATE BIO INC·Filed 2017·Granted Mar 26, 2019·35 cites·13 claims
- 0698US11547764B2Lipid nanoparticle compositions and methods for MRNA deliveryTRANSLATE BIO INC·Filed 2021·Granted Jan 10, 2023·2 cites·13 claims
- 0798US11338044B2Lipid nanoparticle compositions and methods for mRNA deliveryTRANSLATE BIO INC·Filed 2021·Granted May 24, 2022·5 cites·21 claims
- 0898US10507249B2Lipid nanoparticle compositions and methods for mRNA deliveryTRANSLATE BIO INC·Filed 2019·Granted Dec 17, 2019·19 cites·20 claims
- 0998US10413618B2Lipid nanoparticle compositions and methods for mRNA deliveryTRANSLATE BIO INC·Filed 2018·Granted Sep 17, 2019·26 cites·22 claims
- 1098US10350303B1Lipid nanoparticle compositions and methods for mRNA deliveryTRANSLATE BIO INC·Filed 2019·Granted Jul 16, 2019·24 cites·22 claims
- 1198US9308281B2MRNA therapy for Fabry diseaseSHIRE HUMAN GENETIC THERAPIES·Filed 2014·Granted Apr 12, 2016·40 cites·8 claims
- 1298US9061021B2mRNA for use in treatment of human genetic diseasesSHIRE HUMAN GENETIC THERAPIES·Filed 2014·Granted Jun 23, 2015·43 cites·14 claims
- 1398US8853377B2mRNA for use in treatment of human genetic diseasesGUILD BRAYDON CHARLES·Filed 2011·Granted Oct 7, 2014·138 cites·14 claims
- 1497US11234936B2Cleavable lipidsTRANSLATE BIO INC·Filed 2020·Granted Feb 1, 2022·4 cites·18 claims
- 1597US10137087B2Lipid-derived neutral nanoparticlesTRANSLATE BIO INC·Filed 2018·Granted Nov 27, 2018·12 cites·22 claims
- 1697US9956271B2mRNA for use in treatment of human genetic diseasesTRANSLATE BIO INC·Filed 2015·Granted May 1, 2018·11 cites·9 claims
- 1797US9877919B2Lipid-derived neutral nanoparticlesTRANSLATE BIO INC·Filed 2013·Granted Jan 30, 2018·22 cites·15 claims
- 1897US9181321B2CFTR mRNA compositions and related methods and usesSHIRE HUMAN GENETIC THERAPIES·Filed 2014·Granted Nov 10, 2015·50 cites·18 claims
- 1997US8883158B2Compositions and methods for antibodies targeting complement protein C5DIEFENBACH-STREIBER BEATE·Filed 2012·Granted Nov 11, 2014·95 cites·18 claims
- 2097US8241628B2Compositions and methods for antibodies targeting complement protein C5DIEFENBACH-STREIBER BEATE·Filed 2009·Granted Aug 14, 2012·130 cites·20 claims
- 2197US5639641AResurfacing of rodent antibodiesIMMUNOGEN INC·Filed 1992·Granted Jun 17, 1997·870 cites·16 claims
- 2296US10702478B2Cleavable lipidsTRANSLATE BIO INC·Filed 2019·Granted Jul 7, 2020·7 cites·3 claims
- 2396US10143758B2Liver specific delivery of messenger RNATRANSLATE BIO INC·Filed 2013·Granted Dec 4, 2018·28 cites·30 claims
- 2496US9713626B2CFTR mRNA compositions and related methods and usesSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Jul 25, 2017·23 cites·19 claims
- 2596US9597413B2Pulmonary delivery of mRNASHIRE HUMAN GENETIC THERAPIES·Filed 2014·Granted Mar 21, 2017·17 cites·6 claims
- 2695US10786455B2Lipid-derived neutral nanoparticlesTRANSLATE BIO INC·Filed 2018·Granted Sep 29, 2020·5 cites·18 claims
- 2795US10646504B2Synergistic enhancement of the delivery of nucleic acids via blended formulationsTRANSLATE BIO INC·Filed 2018·Granted May 12, 2020·8 cites·14 claims
- 2895US10137086B2Lipid-derived neutral nanoparticlesTRANSLATE BIO INC·Filed 2018·Granted Nov 27, 2018·6 cites·18 claims
- 2995US10130649B2Synergistic enhancement of the delivery of nucleic acids via blended formulationsTRANSLATE BIO INC·Filed 2014·Granted Nov 20, 2018·15 cites·14 claims
- 3095US9717690B2Cleavable lipidsGUILD BRAYDON CHARLES·Filed 2012·Granted Aug 1, 2017·37 cites·36 claims
- 3195US2025108126A1Lipid Nanoparticle Compositions and Methods for mRNA DeliveryTRANSLATE BIO INC·Filed 2024·Application pending·0 cites
- 3294US12331005B2Ionizable cationic lipidsTRANSLATE BIO INC·Filed 2024·Granted Jun 17, 2025·0 cites·17 claims
- 3393US11497716B2Lipid-derived neutral nanoparticlesTRANSLATE BIO INC·Filed 2020·Granted Nov 15, 2022·2 cites·25 claims
- 3493US10507183B2Cleavable lipidsTRANSLATE BIO INC·Filed 2018·Granted Dec 17, 2019·9 cites·3 claims
- 3593US9546128B2Ionizable cationic lipidsSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Granted Jan 17, 2017·12 cites·33 claims
- 3692US10766852B2Ionizable cationic lipidsTRANSLATE BIO INC·Filed 2018·Granted Sep 8, 2020·5 cites·18 claims
- 3792US10065919B2Ionizable cationic lipidsTRANSLATE BIO INC·Filed 2016·Granted Sep 4, 2018·7 cites·23 claims
- 3892US2024425442A1Ionizable cationic lipidsTRANSLATE BIO INC·Filed 2024·Application pending·0 cites
- 3990US11951180B2Lipid nanoparticle compositions and methods for MRNA deliveryTRANSLATE BIO INC·Filed 2023·Granted Apr 9, 2024·0 cites·20 claims
- 4090US11951179B2Lipid nanoparticle compositions and methods for MRNA deliveryTRANSLATE BIO INC·Filed 2023·Granted Apr 9, 2024·0 cites·19 claims
- 4190US11951181B2Lipid nanoparticle compositions and methods for mRNA deliveryTRANSLATE BIO INC·Filed 2023·Granted Apr 9, 2024·0 cites·19 claims
- 4290US11090264B2Pulmonary delivery of mRNA to non-lung target cellsTRANSLATE BIO INC·Filed 2019·Granted Aug 17, 2021·3 cites·2 claims
- 4390US10087247B2Methods and compositions for delivering mRNA coded antibodiesTRANSLATE BIO INC·Filed 2014·Granted Oct 2, 2018·10 cites·17 claims
- 4490US2024342307A1Liver Specific Delivery of Messenger RNATRANSLATE BIO INC·Filed 2024·Application pending·0 cites
- 4589US11999675B2Ionizable cationic lipidsTRANSLATE BIO INC·Filed 2020·Granted Jun 4, 2024·1 cites·18 claims
- 4689US11254936B2Nuclease resistant polynucleotides and uses thereofTRANSLATE BIO INC·Filed 2018·Granted Feb 22, 2022·3 cites·11 claims
- 4789US11135274B2MRNA for use in treatment of human genetic diseasesTRANSLATE BIO INC·Filed 2018·Granted Oct 5, 2021·2 cites·3 claims
- 4888US2024408020A1Lyophilized Pharmaceutical Compositions Comprising a Lipid NanoparticleTRANSLATE BIO INC·Filed 2024·Application pending·0 cites
- 4988US2024123084A1Liver specific delivery of messenger rnaTRANSLATE BIO INC·Filed 2023·Application pending·0 cites
- 5087US10245229B2Pulmonary delivery of mRNA to non-lung target cellsSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Granted Apr 2, 2019·8 cites·18 claims
Showing the top 50 of 90 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Braydon Charles Guild files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →